Remove Chemotherapy Remove Documentation Remove Patient Care
article thumbnail

The changing treatment landscape of acute lymphoblastic leukaemia

Hospital Pharmacy Europe

The CAR T-cell therapy tisagenlecleucel has recently been given the green light for routine rollout on the NHS to treat paediatric patients with acute lymphoblastic leukaemia. These patients often reach the ceiling for toxicity in terms of chemotherapy and radiotherapy in the context of a bone marrow transplant.